3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
214
Lung Neoplasms
74
Neoplasms
24
Adenocarcinoma of Lung
16
Neoplasm Metastasis
15
Mesothelioma, Malignant
15
Parkinson Disease 4, Autosomal Dominant Lewy Body
12
Mesothelioma
12
Carcinoma
11
Head and Neck Neoplasms
10
Breast Neoplasms
8
Adenocarcinoma, Bronchiolo-Alveolar
7
Small Cell Lung Carcinoma
6
Ovarian Neoplasms
6
Recurrence
5
Pancreatic Neoplasms
4
Colorectal Neoplasms
4
Adenocarcinoma
4
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Prostatic Neoplasms
3
Lung Diseases
3
Laryngeal Diseases
3
Carcinoma, Small Cell
3
Brain Neoplasms
3
Uterine Neoplasms
2
Uterine Cervical Neoplasms
2
Thoracic Neoplasms
2
Solitary Fibrous Tumor, Pleural
2
Interventions
Temozolomide
14
Bevacizumab
11
Erlotinib Hydrochloride
5
Radiotherapy
4
Carboplatin
4
Magnetic Resonance Spectroscopy
3
Irinotecan
3
Immunoglobulin G
3
Disulfides
3
temsirolimus
2
poly ICLC
2
palbociclib
2
etoposide phosphate
2
antineoplaston AS 2-1
2
antineoplaston A10
2
Vincristine
2
Sunitinib
2
Sirolimus
2
Everolimus
2
Dasatinib
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
veliparib
1
varlilumab
1
vandetanib
1
trebananib
1
trametinib
1
terameprocol
1
tandutinib
1
selinexor
1
romidepsin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Oligodendroglioma
×
Pemetrexed
×
Clear all
No trials found.